A. Disorders of the digestive system which result in disability usually
do so because of interference with nutrition and growth, multiple recurrent inflammatory lesions, or other complications of
the disease. Such lesions or complications usually respond to treatment. To constitute a listed impairment, these must be
shown to have persisted or be expected to persist despite prescribed therapy for a continuous period of at least 12 months.
B. Documentation of gastrointestinal impairments should include pertinent operative
findings, appropriate medically acceptable imaging studies, endoscopy, and biopsy reports. Where a liver biopsy has been performed
in chronic liver disease, documentation should include the report of the biopsy. Medically acceptable imaging includes, but
is not limited to, x-ray imaging, computerized axial tomography (CAT scan) or magnetic resonance imaging (MRI), with
or without contrast material, myelography, and radionuclear bone scans. "Appropriate" means that the technique used
is the proper one to support the evaluation and diagnosis of the impairment.
retardation and malnutrition. When the primary disorder of the digestive tract has been documented, evaluate resultant
malnutrition under the criteria described in 105.08. Evaluate resultant growth impairment under the criteria described
in 100.03. Intestinal disorders, including surgical diversions and potentially correctable congenital lesions, do not represent
a severe impairment if the individual is able to maintain adequate nutrition, growth and development.
D. Multiple congenital anomalies. See related criteria, and consider as a combination of impairments.
105.01 Category of Impairments, Digestive
105.03 Esophageal Obstruction, caused by atresia, stricture, or stenosis with malnutrition as described under
the criteria in 105.08.
105.05 Chronic Liver Disease. With one of the following:
biliary atresia demonstrated by appropriate medically acceptable imaging or surgery; or
Intractable ascites not attributable to other causes, with serum albumin of 3.0 gm./100 ml. or less; or
C. Esophageal varices (demonstrated by endoscopy or other appropriate medically acceptable imaging); or
D. Hepatic coma, documented by findings from hospital records; or
E. Hepatic encephalopathy. Evaluate under the criteria in 112.02; or
Chronic active inflammation or necrosis documented by SGOT persistently more than 100 units or serum bilirubin of 2.5 mg.
percent or greater.
105.07 Chronic inflammatory bowel disease (such as ulcerative colitis, regional enteritis), as documented in 105.00.
With one of the following:
A. Intestinal manifestations or complications, such
as obstruction, abscess, or fistula formation which has lasted or is expected to last 12 months; or
B. Malnutrition as described under the criteria in 105.08; or
impairment as described under the criteria in 100.03.
105.08 Malnutrition, due to demonstrable gastrointestinal disease causing either a fall of 15 percentiles of weight which persists or the
persistence of weight which is less than the third percentile (on standard growth charts). And one of the following:
A. Stool fat excretion per 24 hours:
1. More than
15 percent in infants less than 6 months.
2. More than 10 percent in infants 6-18
3. More than 6 percent in children more than 18 months; or
B. Persistent hematocrit of 30 percent or less despite prescribed therapy; or
Serum carotene of 40 mcg./100 ml. or less; or
D. Serum albumin of 3.0 gm./100 ml.
105.09 Liver Transplant. Consider under a disability for 12 months following the date of surgery; thereafter,
evaluate the residual impairment.